Teniloxazine manufacturers
- Teniloxazine USP/EP/BP
-
- $1.10
-
2026-08-20
- CAS:62473-79-4
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons Min
- Teniloxazine
-
- $210.00
-
2026-05-11
- CAS:62473-79-4
- Purity: 99.29%
- Supply Ability: 10g
|
| | Teniloxazine Basic information |
| Product Name: | Teniloxazine | | Synonyms: | Teniloxazine;Teniloxazine [inn];Unii-95Q6wnp25p;Morpholine, 2-[[2-(2-thienylmethyl)phenoxy]methyl]-;Teniloxazine USP/EP/BP | | CAS: | 62473-79-4 | | MF: | C16H19NO2S | | MW: | 289.39 | | EINECS: | | | Product Categories: | | | Mol File: | 62473-79-4.mol |  |
| | Teniloxazine Chemical Properties |
| Boiling point | 425.3±35.0 °C(Predicted) | | density | 1.148±0.06 g/cm3(Predicted) | | pka | 8.46±0.40(Predicted) |
| | Teniloxazine Usage And Synthesis |
| Uses | Teniloxazine is an inhibitor for norepinephrine neuronal reuptake and an weak inhibitor for reuptake of Serotonin (HY-B1473A) and Dopamine (HY-B0451). Teniloxazine exhibits antidepressant, antihypoxic and anti-amnestic properties without anticholinergic, sedative, and cardiovascular adverse effects[1]. | | References | [1] Orlando R, et al., The pharmacokinetics of teniloxazine in healthy subjects and patients with hepatic cirrhosis. Br J Clin Pharmacol. 1995 Apr;39(4):445-8. DOI:10.1111/j.1365-2125.1995.tb04475.x |
| | Teniloxazine Preparation Products And Raw materials |
|